Clinical Trial Update: A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV) [Phase 1]

View source ↗

Summary

Phase 1 trial of an Alphavirus replicon vaccine for Cytomegalovirus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• CMV Alphavirus Replicon Vaccine (Alphavirus replicon CMV vaccine)

Snippet

Sponsor: AlphaVax, Inc. | Conditions: Cytomegalovirus Infections | Phase 1 | Status: COMPLETED